Inhibition of the Mitochondrial Complex I Activity by Fatty Acid Derivatives of Vanillylamide

  • Yoshiharu Shimomura
  • Teruo Kawada
  • Kazumi Tagami
  • Masashige Suzuki


Fatty acid derivatives of vanillylamide were found to inhibit the mitochondrial NADH oxidase activity, but almost not the succinate oxidase activity. These results suggest that the compounds are specific inhibitors of the Complex I activity. A study using purified Complex I demonstrated that the compounds inhibit NADH-coenzyme Q reductase activity of the enzyme. However, these did not inhibit rotenone-insensitive NADH-menadione reductase activity and electron transfer from NADH through iron-sulfur centers in Complex I. Kinetic analyses with double-reciprocal plots showed that these compounds were competitive inhibitors with respect to coenzyme Q1. These findings suggest that the compounds bind to the coenzyme Q binding site of Complex I. The natures of acyl groups greatly affected the inhibitory potencies of the compounds, suggesting that the acyl group of compound is important for the binding of compound to the binding site of Complex I.


Reductase Activity Difference Spectrum Cholic Acid Mitochondrial Complex Fatty Acid Derivative 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Suzuki, T., and Iwai, K., (1984) in The Alkaloids (Brossi, A., Ed.), Vol. 23, pp. 227–299, Academic Press, New York.Google Scholar
  2. 2.
    Joo, F., Szolcsanyi, J., and Jancso-Gabor, A. (1969) Life Sci. 8, 621–626.PubMedCrossRefGoogle Scholar
  3. 3.
    Szolcsanyi, J., Joo, F., and Jancso-Gabor, A. (1971) Nature (London) 229, 116–117.CrossRefGoogle Scholar
  4. 4.
    Chudapongse, P., and Janthasoot, W. (1976) Toxicol. Appl. Pharmacol. 37, 263–270.PubMedCrossRefGoogle Scholar
  5. 5.
    Chudapongse, P., and Janthasoot, W. (1981) Biochem. Pharmacol. 30, 735–740.PubMedCrossRefGoogle Scholar
  6. 6.
    Shimomura, Y., Kawada, T., and Suzuki, M. (1989) Arch. Biochem. Biophys. 270, 573–577.PubMedCrossRefGoogle Scholar
  7. 7.
    Schnaitman, C., and Greenawalt, J. W. (1968) J. Cell Biol. 38, 158–175.PubMedCrossRefGoogle Scholar
  8. 8.
    Hatefi, Y. (1978) Methods Enzymol. 53, 11–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Hatefi, Y., and Stiggall, D. L. (1978) Methods Enzymol. 53, 5–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Rangoonwala, R., and Seitz, G. (1970) Dtsche. Apoth. Ztg. 110, 1946–1949.Google Scholar
  11. 11.
    Ohnishi, T., and Leigh, J. S. (1974) Biochem. Biophys. Res. Commun. 56,775–782.CrossRefGoogle Scholar
  12. 12.
    Crane, F. L., and Barr, R. (1971) Methods Enzymol. 18, 137–165.CrossRefGoogle Scholar
  13. 13.
    Hartree, E. F. (1972) Anal. Biochem. 48, 422–427.PubMedCrossRefGoogle Scholar
  14. 14.
    Ragan, C. I. (1976) Biochim. Biophys. Acta 456, 249–290.PubMedGoogle Scholar
  15. 15.
    Nopanitaya, W., and Nye, S. W. (1974) Toxicol. Appl. Phamacol. 30, 149–161.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Yoshiharu Shimomura
    • 1
  • Teruo Kawada
    • 2
  • Kazumi Tagami
    • 1
  • Masashige Suzuki
    • 1
  1. 1.Laboratory of Biochemistry of Exercise and Nutrition Institute of Health and Sport SciencesUniversity of TsukubaTsukuba 305Japan
  2. 2.Laboratory of Nutritional Chemistry, Department of Food Science and Technology Faculty of AgricultureKyoto UniversityKyoto 606Japan

Personalised recommendations